Business
Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.
LITTLETON, Colo., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders (including all severities of obstructive sleep apnea (OSA) and snoring in adults and moderate to severe OSA in children ages 6 – 17), today announced that the Company’s CEO Kirk Huntsman will part
About this update from Vivos Therapeutics, Inc.
[{"type":"image","alt":"Vivos Therapeutics, Inc","displaySize":"","headline":null,"caption":"Vivos Therapeutics, Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":148,"height":46,"url":"https://media.zenfs.com/en/globenewswire.com/452f3e3cd3796a0ed8557400112a2519"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/o.bVqaj5F3NG9.btjYGvyg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTY1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/452f3e3cd3796a0ed8557400112a2519","width":148,"height":46}},"lazy":false},{"type":"text","content":"LITTLETON, Colo., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders (including all severities of obstructive sleep apnea (OSA) and snoring in adults and moderate to severe OSA in children ages 6 – 17), today announced that the Company’s CEO Kirk Huntsman will participate in a fireside chat with Do Kim, senior research analyst of Water Tower Research ("WTR") on Tuesday, February 18, 2025, at 12:00 pm ET.","length":652,"tagName":"p"},{"type":"text","content":"Mr. Huntsman will provide an overview of the Company and its Vivos CARE devices for OSA, the strategic shift to a medical-based business model, its efforts to secure alliances and partnerships with physician-based sleep groups, OSA market dynamics, and how Vivos CARE devices fit in the OSA treatment paradigm.","length":310,"tagName":"p"},{"type":"text","content":"To register for this listen-only event, please visit:","length":53,"tagName":"p"},{"type":"text","content":"Fireside Chat Registration Link","length":31,"tagName":"p"},{"type":"text","content":"The replay of the fireside chat will be available for 30 days in the "Investor Relations" section on the Company’s website at https://vivos.com.","length":154,"tagName":"p"},{"type":"text","content":"About Vivos Therapeutics, Inc.","length":30,"tagName":"p"},{"type":"text","content":"Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obs...